2012 Research Articles
Pathophysiology
Causes/Risk Factors
Associated Diseases
Symptoms
Testing
Antibiotic Treatment: Rifaximin
Probiotics
Microbiome
Low FODMAP DIET
Diet & IBS
- The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time. PMID: 22097886
Causes/Risk Factors
- The migrating motor complex: control mechanisms and its role in health and disease. PMID: 22450306
- Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. PMID: 23270866
- PPI use and SIBO: predisposition or cause? PMID: 23211857
- Proton-pump inhibitor therapy and small bowel bacterial contamination. PMID:22890175
- Ileocecal valve dysfunction in small intestinal bacterial overgrowth: a pilot study. PMID: 23239918
Associated Diseases
- Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test. PMID: 23329223
- Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome? PMID: 23272525
- [Predominance of constipation in subjects with hydrogen-consuming intestinal flora]. - Spanish PMID: 23214347
- Small intestinal bacterial overgrowth in gastroparesis. PMID:23053897
- Erosive esophagitis may be related to small intestinal bacterial overgrowth. PMID: 22416969
Symptoms
Testing
Antibiotic Treatment: Rifaximin
- Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months. PMID:23066911
- Antibiotics for irritable bowel syndrome: rationale and current evidence. PMID: 22945316
- Rifaximin and lubiprostone: the best options for treating irritable bowel syndrome? PMID: 22816171
- Impurity profile of rifaximin produced in China. PMID: 22570932
- Rifaximin for the treatment of irritable bowel syndrome. PMID: 22251066
- Rifaximin Therapy of Irritable Bowel Syndrome. PMID: 24833932
- The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. PMID: 22045120
- Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. PMID: 22155172
Probiotics
- [Lactase deficiency in patients with postinfectious irritable bowel syndrome and the role of intestinal microflora in its development]. – in Russian PMID: 23402179
Microbiome
- The gut microbiota and irritable bowel syndrome: friend or foe? PMID: 22577594
- The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. PMID: 22262197
Low FODMAP DIET
- Dietary modification as a treatment for irritable bowel syndrome. PMID: 23293571
- Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. PMID: 24672410
- Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? PMID: 22778791
- Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. PMID: 22739368
- Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. PMID: 22446969
- The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). PMID: 22366773
Diet & IBS
- Diet and irritable bowel syndrome. PMID: 23256117
- IgG-based elimination diet in migraine plus irritable bowel syndrome. PMID: 23216231
- Diet in subjects with irritable bowel syndrome: a cross-sectional study in the general population. PMID: 22676475
- The value of eliminating foods according to food-specific immunoglobulin G antibodies in irritable bowel syndrome with diarrhoea. PMID: 22429360
If you value this website, consider supporting the free information provided on siboinfo.com and it's newsletter, which helps SIBO sufferers world wide.